TLR4 and neoplasm: In the present study, we demonstrate that B16 cells (a mouse melanoma tumor line) expressing recombinant sCRT39-272 exhibit significantly more malignant behavior in mice, which is attributed to the ability of sCRT39-272 to expand and recruit MDSCs in a TLR4 and S100A8/9-dependent manner.